实用肝脏病杂志 ›› 2025, Vol. 28 ›› Issue (1): 76-79.doi: 10.3969/j.issn.1672-5069.2025.01.020

• 脓毒症相关性肝损伤 • 上一篇    下一篇

32例脓毒症相关性肝损伤患者临床特征及其影响因素分析*

刘斐, 姚杰, 张丽骞, 乔志飞, 高乃坤, 王磊, 刘春艳, 李福龙   

  1. 075000 河北省张家口市 河北北方学院附属第一医院重症医学科(刘斐, 张丽骞, 乔志飞, 高乃坤, 王磊, 刘春艳, 李福龙);麻醉科(姚杰)
  • 收稿日期:2024-09-27 出版日期:2025-01-10 发布日期:2025-02-07
  • 通讯作者: 姚杰,E-mail:Jingjie1229@163.com
  • 作者简介:刘斐,女,37岁,医学硕士,主治医师。E-mail:lf16620118491@163.com
  • 基金资助:
    *河北省卫生健康委科研基金资助项目(编号:20200524);张家口市科技局科研计划自筹经费项目(编号:2021033D)

Clinical feature and risk factors of sepsis-related liver injury: An analysis of 32 cases

Liu Fei, Yao Jie, Zhang Liqian, et al   

  1. Intensive Care Unit, First Affiliated Hospital of Hebei North University, Zhangjiakou 075000, Hebei Province, China
  • Received:2024-09-27 Online:2025-01-10 Published:2025-02-07

摘要: 目的 了解脓毒症相关性肝损伤(SRLI)患者的临床特征并分析潜在的影响因素。方法 2021年1月~2024年4月我院诊治的脓毒症患者175例,其中合并肝损伤32例,分别给予抗感染或/和护肝治疗。采用ELISA法检测血清C-反应蛋白(CRP)、白介素-6(IL-6)和降钙素原(PCT)水平。采用多因素二元Logistic回归分析脓毒症患者发生肝损伤的影响因素。结果 肝损伤组存在糖尿病、慢性肾病、机械通气、呼吸系统感染、胆道系统感染、SOFA评分、APACHE Ⅱ评分、血培养细菌阳性、发生感染性休克或多器官功能衰竭占比均显著高于无肝损伤组(P<0.05);肝损伤组血清ALT、AST、TBIL、CRP、IL-6和PCT水平分别为(92.5±9.7)U/L、(87.5±9.9)U/L、31.4(17.9,56.2)μmol/L、(56.3±12.6)mg/L、130.2(95.2,162.3)pg/L和23.6(11.9,35.0)μg/L,均显著高于无肝损伤组【分别为(36.2±3.5)U/L、(31.5±2.9)U/L、 14.0(9.3,22.4)μmol/L、(9.7±1.7)mg/L、102.4(74.2,139.7)pg/L和11.0(7.7,17.9)μg/L,P<0.05】,而肝损伤组PLT计数和血清Alb水平分别为59.1(46.2,83.4)×109/L和(30.4±2.8)g/L,均显著低于无肝损伤组【分别为95.6(60.3,141.8)×109/L和(33.6±2.5)g/L,P<0.05】;多变量Logistic分析结果发现血清IL-6水平、感染性休克和多器官功能衰竭是脓毒症患者发生肝损伤的独立危险因素(P均<0.05)。结论 脓毒症患者发生肝损伤可能与感染性休克或多器官功能衰竭激起机体炎症反应有关,早期积极防治感染并减少应用损肝药物可能都有重要的临床意义。

关键词: 脓毒症, 肝损伤, 感染性休克, 多器官功能衰竭, 影响因素

Abstract: Objective The aim of this study was to investigate clinical feature and risk factors of sepsis-related liver injury (SRLI). Methods A total of 175 patients with sepsis were enrolled in this studybetween January 2021 and April 2024, and out of them, 32 patients were found having SRLI. Patients were treated with antibiotics and/or liver-protecting medicines. Serum C-reactive protein (CRP), interleukin-6 (IL-6) and procalcitonin (PCT) levels were assayed by ELISA. Multivariate Logistic regression analysis was applied to reveal risk factors.Results Concomitant diabetes, chronic nephropathy, mechanical ventilation, respiratory and biliary tract infection, SOFA and APACHE Ⅱ scores, positive blood bacteria culture, septic shock and multi-organ functional failure (MOFF) in patients with SRLI were all significantly higher than in those without liver injury (P<0.05); serum ALT, AST, total bilirubin, CRP, IL-6 and PCT levels in patients with SRLI were (92.5±9.7)U/L, (87.5±9.9)U/L, 31.4(17.9, 56.2)μmol/L, (56.3±12.6)mg/L, 130.2(95.2, 162.3)pg/L and 23.6(11.9, 35.0)μg/L, all much higher than [(36.2±3.5)U/L, (31.5±2.9)U/L, 14.0(9.3, 22.4)μmol/L, (9.7±1.7)mg/L, 102.4(74.2, 139.7)pg/L and 11.0(7.7, 17.9)μg/L, respectively, P<0.05], while peripheral platelet count and serum albumin level were 59.1(46.2, 83.4)×109/L and (30.4±2.8)g/L, both significantly lower than [95.6(60.3, 141.8)×109/L and (33.6±2.5)g/L, respectively, P<0.05] in those without liver injury; multivariate Logistic regression analysis showed that serum IL-6 level, septic shock and MOFF were all the risk factors for occurrence of liver injury (all P<0.05). Conclusion SRLI could occur in patients with sepsis, especially in those with septic shock and MOFF, which might be related to inflammatory reactions, and early active antimicrobial therapy is essential in reducing liver injury.

Key words: Sepsis-related liver injury, Septic shock, Multi-organ functional failure, Risk factors